- Home
- HLF vs AMLX Comparison
HLF vs AMLX Comparison
Compare HLF & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLF
- AMLX
- Stock Information
- Founded
- HLF 1980
- AMLX 2014
- Country
- HLF United States
- AMLX United States
- Employees
- HLF N/A
- AMLX N/A
- Industry
- HLF Other Pharmaceuticals
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- HLF Health Care
- AMLX Health Care
- Exchange
- HLF Nasdaq
- AMLX Nasdaq
- Market Cap
- HLF 583.2M
- AMLX 481.9M
- IPO Year
- HLF N/A
- AMLX 2022
- Fundamental
- Price
- HLF $8.33
- AMLX $3.30
- Analyst Decision
- HLF Buy
- AMLX Buy
- Analyst Count
- HLF 5
- AMLX 7
- Target Price
- HLF $9.90
- AMLX $7.60
- AVG Volume (30 Days)
- HLF 3.7M
- AMLX 748.4K
- Earning Date
- HLF 02-19-2025
- AMLX 03-04-2025
- Dividend Yield
- HLF N/A
- AMLX N/A
- EPS Growth
- HLF 76.06
- AMLX N/A
- EPS
- HLF 2.50
- AMLX N/A
- Revenue
- HLF $4,993,100,000.00
- AMLX $196,485,000.00
- Revenue This Year
- HLF N/A
- AMLX N/A
- Revenue Next Year
- HLF $1.57
- AMLX N/A
- P/E Ratio
- HLF $3.32
- AMLX N/A
- Revenue Growth
- HLF N/A
- AMLX N/A
- 52 Week Low
- HLF $5.04
- AMLX $1.58
- 52 Week High
- HLF $12.79
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- HLF 77.90
- AMLX 39.44
- Support Level
- HLF $5.57
- AMLX $3.42
- Resistance Level
- HLF $8.40
- AMLX $3.65
- Average True Range (ATR)
- HLF 0.39
- AMLX 0.26
- MACD
- HLF 0.34
- AMLX 0.00
- Stochastic Oscillator
- HLF 97.77
- AMLX 2.94
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management; targeted nutrition; Energy, Sports, and Fitness; Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Mexico, South and Central America, EMEA, Asia-Pacific, and China.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.